Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Xenon to Highlight Phase 3 X-TOLE2 Clinical Data and Rational Polytherapy Potential for Azetukalner at EEC 2026

Six presentations planned, including encore oral presentation of topline X-TOLE2 efficacy and safety results New poster will highlight the mechanistic characterization of azetukalner, including its potential additive effects when used with commonly prescribed ASMs VANCOUVER, BC and BOSTON, MA, Aug. 26, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused…

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Read the original at financialpost.com →

More in Finance & Markets

Measuring Order Book vs AMM Share on the XRP Ledger

When the AMM amendment activated on the XRP Ledger in 2024, the expectation was that liquidity would migrate into pools the way it did on every smart-contract chain before it.

  • 89% of XRP Ledger volume comes from order books
  • AMM pools account for only 11% of global volume
  • Order books retain viability due to low cancellation costs

More from Wednesday 26 August →